Browse by author
Lookup NU author(s): Dr Barry Davies
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Metastasis is usually responsible for mortality in patients suffering from muscle invasive bladder cancer. Whilst expression of a great number of genes and their protein products have been associated with metastasis and/or poor prognosis in bladder cancer, evidence that they actively drive the metastatic process, and hence make potentially good therapeutic targets, is often lacking. This is due to the limited number and application of effective animal models which reflect the pathogenesis of the human disease. In this review I will discuss the processes involved in metastasis, consider the established animal models of bladder cancer progression and metastasis, and review the evidence for a role of various gene products in this process. Consideration of clinical studies in conjunction with evidence from experimental animal models reveals that the tyrosine kinase receptor erbB1/EGFR, the calcium binding protein S100A4 and the the cell cycle arrest/apoptosis-inducing p53 protein are amongst the most promising targets for therapy against metastatic disease in patients with bladder cancer.
Author(s): Davies BR
Publication type: Review
Publication status: Published
Journal: Histology and Histopathology
Print publication date: 01/07/2003
ISSN (print): 0213-3911
ISSN (electronic): 1699-5848
PubMed id: 12792907